Date Filed | Type | Description |
12/13/2022 |
4
| Lubniewski John L (President & CEO) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC
Txns:
| Granted 1,000 shares
@ $0.425, valued at
$425 |
|
08/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/04/2022 |
4
| Lubniewski John L (President & CEO) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC
Txns:
| Paid exercise price by delivering 62 shares
@ $1.39, valued at
$86.2 |
|
12/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/16/2020 |
4
| Lubniewski John L (President & CEO) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC
Txns:
| Granted 66 shares
@ $4.8705, valued at
$321.5 |
|
10/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/24/2020 |
4
| Lubniewski John L (President & CEO) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC
Txns:
| Granted 1,200,000 options to buy
@ $0.48, valued at
$576k
|
|
07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/15/2020 |
4
| Lubniewski John L (President & CEO) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC
Txns:
| Granted 1,000 shares
@ $0.5525, valued at
$552.5 |
|
04/02/2020 |
4
| Lubniewski John L (President & CEO) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC
Txns:
| Paid exercise price by delivering 1,086 shares
@ $0.33, valued at
$358.4 |
|
01/27/2020 |
4
| Lubniewski John L (President & CEO) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC
Txns:
| Granted 537,500 options to buy
@ $0.66, valued at
$354.8k
|
|
01/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/12/2019 |
4
| Lubniewski John L (President & CEO) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC
Txns:
| Granted 701 shares
@ $0.5656, valued at
$396.5 |
|
10/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/19/2019 |
4
| Lubniewski John L (President & CEO) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC
Txns:
| Granted 112,500 options to buy
@ $0.95, valued at
$106.9k
|
|
07/03/2019 |
4
| Lubniewski John L (President & CEO) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC
Txns:
| Paid exercise price by delivering 921 shares
@ $1.66, valued at
$1.5k
|
|
06/13/2019 |
4
| Lubniewski John L (President & CEO) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC
Txns:
| Granted 761 shares
@ $1.5725, valued at
$1.2k
|
|
05/24/2019 |
4
| Lubniewski John L (President & CEO) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC
Txns:
| Granted 300,000 options to buy
@ $2.22, valued at
$666k
|
|
04/01/2019 |
4
| Lubniewski John L (President & CEO) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC
Txns:
| Paid exercise price by delivering 909 shares
@ $2.5, valued at
$2.3k
|
|
01/02/2019 |
4
| Lubniewski John L (President & COO) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC
Txns:
| Paid exercise price by delivering 921 shares
@ $2.54, valued at
$2.3k
|
|
12/17/2018 |
4
| Lubniewski John L (President & COO) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC
Txns:
| Acquired 735 shares
@ $1.5725, valued at
$1.2k
|
|
10/02/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/17/2018 |
4
| Lubniewski John L (President & COO) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC
Txns:
| Granted 50,000 shares
@ $0 Granted 100,000 options to buy
@ $3.4, valued at
$340k
|
|
06/14/2018 |
4
| Lubniewski John L (President & COO) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC
Txns:
| Acquired 788 shares
@ $1.5725, valued at
$1.2k
|
|
01/31/2018 |
4
| Lubniewski John L (SVP, Chief Business Officer) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC
Txns:
| Granted 63,483 shares
@ $0 |
|
12/15/2017 |
4
| Lubniewski John L (Chief Business Officer) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC
Txns:
| Acquired 818 shares
@ $1.6065, valued at
$1.3k
|
|
07/17/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|